Gregory de Lissovoy
MEDTAP International Incorporated
Center of Health Economics
Bethesda
MD 20814
USA
Name/email consistency: high
- Economic analysis of unrelated allogeneic bone marrow transplantation: results from the randomized clinical trial of T-cell depletion vs unmanipulated grafts for the prevention of graft-versus-host disease. de Lissovoy, G., Hurd, D., Carter, S., Beatty, P., Ewell, M., Henslee-Downey, J., Kernan, N., Yanovich, S., Weisdorf, D. Bone Marrow Transplant. (2005)
- Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failure. de Lissovoy, G., Stier, D.M., Ciesla, G., Munger, M., Burger, A.J. Am. J. Cardiol. (2003)
- Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective. de Lissovoy, G., Subedi, P. Am. J. Manag. Care (2002)
- Relationship of hemoglobin A1c, age of diabetes diagnosis, and ethnicity to clinical outcomes and medical costs in a computer-simulated cohort of persons with type 2 diabetes. de Lissovoy, G., Ganoczy, D.A., Ray, N.F. Am. J. Manag. Care (2000)
- Cost for inpatient care of venous thrombosis: a trial of enoxaparin vs standard heparin. de Lissovoy, G., Yusen, R.D., Spiro, T.E., Krupski, W.C., Champion, A.H., Sorensen, S.V. Arch. Intern. Med. (2000)